Stock Quote & Chart (TRDA) Previous Close Open Volume Exchange Day High Day Low 52-Week High 52-Week Low Last Updated: 5 Mar, 2024 7:54 AM EST Minimum 15 minute delay Data Provided by Refinitiv. Minimum 15 minutes delayed. Analyst Coverage Entrada Therapeutics is followed by the analysts named below Company Name Evercore ISI Umer Raffat and Jonathan Miller, PhD Goldman Sachs Chris Shibutani, MD and Stephen Sloan, PhD H.C. Wainwright Boobalan Pachaiyappan, PhD and Raghuram Selvaraju, PhD Oppenheimer Hartaj Singh TD Cowen Joseph Thome, PhD William Blair Myles Minter Entrada Therapeutics is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Entrada Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Entrada Therapeutics or its management. Entrada Therapeutics does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.